Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Highlights of the 2012 Aspirin Foundation meeting

Nick Henderson – Executive Director, Aspirin Foundation
Highlights of the 2012 Aspirin Foundation meeting ( Nick Henderson – Executive Director, Aspirin Foundation )
1 Nov 2012

Effects of aspirin on the progression of cancer

Prof Peter Rothwell – Oxford University, UK
Effects of aspirin on the progression of cancer ( Prof Peter Rothwell – Oxford University, UK )
1 Nov 2012

Side effects of treating with aspirin

Prof Peter Elwood – Cardiff University, UK
Side effects of treating with aspirin ( Prof Peter Elwood – Cardiff University, UK )
1 Nov 2012

Recent evidence to support the use of aspirin in the treatment of cancer

Dr Ruth Langley – Medical Research Council, London, UK
Recent evidence to support the use of aspirin in the treatment of cancer ( Dr Ruth Langley – Medical Research Council, London, UK )
1 Nov 2012

Aspirin in cardiovascular disease

Prof Carlo Patrono – Catholic University School of Medicine in Rome, Italy
Aspirin in cardiovascular disease ( Prof Carlo Patrono – Catholic University School of Medicine in Rome, Italy )
1 Nov 2012

Effectiveness of PARP inhibitors in ovarian cancer

Prof Jonathan Ledermann - University College London, UK
Effectiveness of PARP inhibitors in ovarian cancer ( Prof Jonathan Ledermann - University College London, UK )
1 Nov 2012

Phase III HECTOR study: recurring platinum sensitive ovarian cancer

Prof Sven Mahner - University Medical Center Hamburg-Eppendorf , Hamburg, Germany
Phase III HECTOR study: recurring platinum sensitive ovarian cancer ( Prof Sven Mahner - University Medical Center Hamburg-Eppendorf , Hamburg, Germany )
31 Oct 2012

GOG 209 study: optimal management of advanced endometrial cancer

Prof David Miller – University of Texas Southwestern Medical Centre, Dallas, USA
GOG 209 study: optimal management of advanced endometrial cancer ( Prof David Miller – University of Texas Southwestern Medical Centre, Dallas, USA )
31 Oct 2012

The Cancer Genome Atlas and high grade serous ovarian cancer

Dr Andrew Berchuck – Duke University Medical Center, Durham, USA
The Cancer Genome Atlas and high grade serous ovarian cancer ( Dr Andrew Berchuck – Duke University Medical Center, Durham, USA )
30 Oct 2012

Gestational trophoblastic disease tumours in high risk patients

Dr Michael Seckl – Charing Cross Hospital, Imperial College London, UK
Gestational trophoblastic disease tumours in high risk patients ( Dr Michael Seckl – Charing Cross Hospital, Imperial College London, UK )
30 Oct 2012

Defining and advancing individualised medicine

Prof Anil Sood – MD Anderson Cancer Centre, Houston, USA
Defining and advancing individualised medicine ( Prof Anil Sood – MD Anderson Cancer Centre, Houston, USA )
29 Oct 2012

6th International Workshop on Myeloma Pharmacogenomics and Novel Therapeutics

Prof Keith Stewart, Prof Gareth Morgan, Dr Stuart Smith
6th International Workshop on Myeloma Pharmacogenomics and Novel Therapeutics ( Prof Keith Stewart, Prof Gareth Morgan, Dr Stuart Smith )
23 Oct 2012